Bronte Capital Management Pty Ltd. Sells 3,085 Shares of iShares Biotechnology ETF $IBB

Bronte Capital Management Pty Ltd. decreased its holdings in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 4.3% in the 1st quarter, according to its most recent Form 13F filing with the SEC. The firm owned 69,265 shares of the financial services provider’s stock after selling 3,085 shares during the period. iShares Biotechnology ETF makes up about 1.2% of Bronte Capital Management Pty Ltd.’s holdings, making the stock its 19th largest holding. Bronte Capital Management Pty Ltd.’s holdings in iShares Biotechnology ETF were worth $11,695,000 at the end of the most recent quarter.

Several other large investors also recently added to or reduced their stakes in the business. Basepoint Wealth LLC purchased a new stake in shares of iShares Biotechnology ETF in the 4th quarter valued at about $26,000. Cary Street Partners Financial LLC purchased a new position in shares of iShares Biotechnology ETF during the fourth quarter worth about $29,000. Darwin Wealth Management LLC bought a new position in shares of iShares Biotechnology ETF in the second quarter worth approximately $25,000. Caitlin John LLC bought a new position in shares of iShares Biotechnology ETF in the fourth quarter worth approximately $34,000. Finally, Cornerstone Planning Group LLC bought a new position in shares of iShares Biotechnology ETF in the fourth quarter worth approximately $35,000. Institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Price Performance

Shares of NASDAQ:IBB opened at $195.70 on Friday. iShares Biotechnology ETF has a one year low of $127.11 and a one year high of $195.99. The company’s fifty day moving average price is $172.76 and its 200-day moving average price is $171.67.

iShares Biotechnology ETF Cuts Dividend

The company also recently announced a quarterly dividend, which was paid on Thursday, June 18th. Investors of record on Monday, June 15th were paid a $0.0238 dividend. This represents a $0.10 dividend on an annualized basis and a yield of 0.0%. The ex-dividend date of this dividend was Monday, June 15th.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.